4//SEC Filing
BUCHAN JANE 4
Accession 0001641172-25-016110
CIK 0001873835other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:57 PM ET
Size
6.3 KB
Accession
0001641172-25-016110
Insider Transaction Report
Form 4
BUCHAN MELISSA JANE
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-20+33,000→ 33,000 totalExercise: $2.24Exp: 2035-06-20→ Common Stock (33,000 underlying)
Holdings
- 22,455
Common Stock
Footnotes (1)
- [F1]The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.
Documents
Issuer
Immix Biopharma, Inc.
CIK 0001873835
Entity typeother
Related Parties
1- filerCIK 0001342502
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 4:57 PM ET
- Size
- 6.3 KB